Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Changwon Fatima Hospital, Changwon, Korea.
Diabetes Metab J. 2024 May;48(3):327-339. doi: 10.4093/dmj.2023.0350. Epub 2024 Feb 2.
It has been generally accepted that insulin resistance (IR) and reduced insulin secretory capacity are the basic pathogenesis of type 2 diabetes mellitus (T2DM). In addition to genetic factors, the persistence of systemic inflammation caused by obesity and the associated threat of lipotoxicity increase the risk of T2DM. In particular, the main cause of IR is obesity and subjects with T2DM have a higher body mass index (BMI) than normal subjects according to recent studies. The prevalence of T2DM with IR has increased with increasing BMI during the past three decades. According to recent studies, homeostatic model assessment of IR was increased compared to that of the 1990s. Rising prevalence of obesity in Korea have contributed to the development of IR, non-alcoholic fatty liver disease and T2DM and cutting this vicious cycle is important. My colleagues and I have investigated this pathogenic mechanism on this theme through clinical and experimental studies over 20 years and herein, I would like to summarize some of our studies with deep gratitude for receiving the prestigious 2023 Sulwon Award.
一般认为,胰岛素抵抗(IR)和胰岛素分泌能力降低是 2 型糖尿病(T2DM)的基本发病机制。除了遗传因素外,肥胖引起的全身性炎症持续存在以及随之而来的脂毒性威胁,增加了 T2DM 的发病风险。特别是,IR 的主要原因是肥胖,根据最近的研究,T2DM 患者的体重指数(BMI)高于正常人群。在过去的三十年中,随着 BMI 的增加,IR 合并 T2DM 的患病率也有所增加。最近的研究表明,与 20 世纪 90 年代相比,稳态模型评估的胰岛素抵抗增加了。韩国肥胖症的流行导致了 IR、非酒精性脂肪肝和 T2DM 的发生,打破这个恶性循环很重要。我的同事和我通过 20 多年的临床和实验研究,针对这一发病机制进行了调查,在此,我非常感谢获得 2023 年苏尔文奖,对这一主题进行了总结。